7786 J. Am. Chem. Soc., Vol. 123, No. 32, 2001
Lakshman et al.
NMR spectra were obtained at 500 MHz; chemical shifts (δ) are
reported in ppm, and coupling constants (J) are in Hz.
0.11 (2s, 12H, Si-CH3). HRMS calcd for C28H43N5O5Si2Na (M+
+
Na), 608.2700. Found, 608.2704.
Typical Procedure for the Coupling of Bromonucleoside 1 with
Arylboronic Acids. In an oven-dried, screw-cap vial equipped with a
stirring bar were placed Pd(OAc)2 (2 mg, 8.9 µmol), L-4 (4.8 mg, 13.6
µmol), the boronic acid (1.5 molar equiv), and K3PO4 (39 mg, 0.18
mmol). Finally, the bromonucleoside (1, 50 mg, 0.092 mmol) was
added, followed by the addition of freshly distilled, dry 1,4-dioxane
(0.6 mL). The vial was flushed with nitrogen, sealed with a Teflon-
lined cap, and placed in a sand bath that was maintained at 100-102
°C. The reactions were monitored by TLC, and upon completion, the
reaction mixtures were filtered through Celite. In each case, the residue
was washed with CH2Cl2 and the filtrate was evaporated to dryness.
The products were purified by column chromatography on silica gel
using appropriate solvents (listed under individual compound headings,
vide infra). Fractions that contained the pure products were combined,
evaporated and finally dried under high vacuum to remove traces of
solvent.
6-Phenyl-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deoxynebu-
larine (4a). Chromatography, CH2Cl2, followed by 2% acetone in CH2-
Cl2. Colorless oil, Rf (2% acetone in CH2Cl2) ) 0.31. 1H NMR
(CDCl3): 9.02 (s, 1H, purine-H), 8.79-8.77 (m, 2H, Ar-H), 8.43 (s,
1H, purine-H), 7.60-7.52 (m, 3H, Ar-H), 6.59 (t, 1H, 1′, J ) 6.5),
4.67 (m, 1H, 3′), 4.07 (app q, 1H, 4′, J ∼ 3.6), 3.90 (dd, 1H, 5′, J )
4.3, 11.2), 3.81 (dd, 1H, 5′, J ) 3.2, 11.2), 2.73 (app sept, 1H, 2′, J )
5.9, 6.9, 13.0), 2.51 (ddd, 1H, 2′, J ) 3.7, 6.1, 13.1), 0.94, 0.92 (2s,
18H, C(CH3)3), 0.13, 0.10, 0.098 (3s, 12H, Si-CH3). HRMS calcd for
C28H44N4O3Si2Na (M+ + Na), 563.2850. Found, 563.2864.
6-(4-Methoxyphenyl)-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deox-
ynebularine (4b). Chromatography, CH2Cl2, followed by 2% acetone
in CH2Cl2. Colorless oil, Rf (2% acetone in CH2Cl2) ) 0.11. 1H NMR
(CDCl3): 8.96 (s, 1H, purine-H), 8.81 (d, 2H, Ar-H, J ) 9.0), 8.40 (s,
1H, purine-H), 7.09 (d, 2H, Ar-H, J ) 9.0), 6.57 (t, 1H, 1′, J ) 6.5),
4.66 (m, 1H, 3′), 4.06 (app q, 1H, 4′, J ∼ 3.6), 3.91 (s, 3H, OCH3),
3.89 (dd, 1H, 5′, J ) 4.3, 11.2), 3.80 (dd, 1H, 5′, J ) 3.2, 11.2), 2.72
(app sept, 1H, 2′, J ) 6.0, 6.8, 13.0), 2.50 (ddd, 1H, 2′, J ) 3.7, 6.1,
13.0), 0.94, 0.92 (2s, 18H, C(CH3)3), 0.13, 0.10, 0.098 (3s, 12H, Si-
CH3). HRMS calcd for C29H46N4O4Si2Na (M+ + Na), 593.2955. Found,
593.2960.
6-(4-Acetylphenyl)-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deox-
ynebularine (4f). Chromatography, CH2Cl2 followed by 2% acetone
in CH2Cl2. Colorless oil, Rf (2% acetone in CH2Cl2) ) 0.17. 1H NMR
(CDCl3): 9.06 (s, 1H, purine-H), 8.91 (d, 2H, Ar-H, J ) 8.5), 8.50 (s,
1H, purine-H), 8.15 (d, 2H, Ar-H, J ) 8.5), 6.60 (t, 1H, 1′, J ) 6.4),
4.67 (m, 1H, 3′), 4.08 (app q, 1H, 4′, J ∼ 3.5), 3.91 (dd, 1H, 5′, J )
4.1, 11.2), 3.81 (dd, 1H, 5′, J ) 3.1, 11.2), 2.72 (app quint, 1H, 2′,
J ∼ 6.1), 2.69 (s, 3H, COCH3), 2.52 (ddd, 1H, 2′, J ) 3.8, 6.1, 13.1),
0.94, 0.92 (2s, 18H, C(CH3)3), 0.13, 0.11 (2s, 12H, Si-CH3). HRMS
calcd for C30H47N4O4Si2 (M+ + H), 583.3136. Found, 583.3134.
6-(3-Thiopheno)-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deoxyneb-
ularine (4g). Chromatography, CH2Cl2, followed by 5% EtOAc in CH2-
Cl2. Colorless oil, Rf (5% EtOAc in CH2Cl2) ) 0.35. 1H NMR
(CDCl3): 8.95 (s, 1H, purine-H), 8.93 (dd, 1H, Ar-H, J ) 1.1, 3.1),
8.43 (s, 1H, purine-H), 8.29 (dd, 1H, Ar-H, J ) 1.1, 5.1), 7.46 (dd,
1H, Ar-H, J ) 3.1, 5.1), 6.57 (t, 1H, 1′, J ) 6.4), 4.66 (m, 1H, 3′),
4.06 (app q, 1H, 4′, J ∼ 3.6), 3.90 (dd, 1H, 5′, J ) 4.2, 11.2), 3.80
(dd, 1H, 5′, J ) 3.2, 11.2), 2.71 (app quint, 1H, 2′, J ∼ 6.7), 2.50
(ddd, 1H, 2′, J ) 3.9, 6.1, 13.1), 0.94, 0.93 (2s, 18H, C(CH3)3), 0.13,
0.11 (2s, 12H, Si-CH3). HRMS calcd for C26H42N4O3SSi2Na (M+
+
Na), 569.2414. Found, 569.2437.
Typical Procedure for the Coupling of Chloronucleoside 2 with
Arylboronic Acids. In an oven-dried, screw-cap vial equipped with a
stirring bar were placed Pd(OAc)2 (2 mg, 8.9 µmol) and L-4 (4.8 mg,
13.6 µmol). Freshly distilled, dry 1,4-dioxane (0.6 mL) was added, the
vial was flushed with nitrogen and sealed with a Teflon-lined cap, and
the mixture was stirred at room temperature for a few minutes. The
boronic acid (1.5 molar equivalents), chloronucleoside (2, 46.0 mg,
0.092 mmol) and K3PO4 (39 mg, 0.18 mmol) were then added to the
vial, the vial was again flushed with nitrogen, sealed with a Teflon-
lined cap, and placed in a sand bath that was maintained at 100-102
°C. Reactions were monitored by TLC, and upon completion, the
reaction mixtures were filtered through Celite. In each case, the residue
was washed with CH2Cl2, and the filtrate was evaporated to dryness.
The products were purified by column chromatography on silica gel
using appropriate solvents (described under the individual compound
headings, vide supra). Fractions that contained the pure products were
combined, evaporated, and finally dried under high vacuum to remove
traces of solvent. The 1H NMR spectra of compounds 4a, 4b, and 4e-g
were identical to those obtained from the bromonucleoside reactions.
Typical Procedure for the Coupling of Bromonucleoside 3 with
Arylboronic Acids. In an oven-dried, screw-cap vial equipped with a
stirring bar were placed Pd(OAc)2 (1.7 mg, 7.5 µmol), L-4 (4.0 mg,
11.4 µmol), the boronic acid (1.5 molar equivalents), and K3PO4 (39
mg, 0.15 mmol). Finally, the bromonucleoside (3, 50 mg, 0.077 mmol)
was added, followed by the addition of freshly distilled, dry 1,4-dioxane
(0.6 mL). The vial was flushed with nitrogen, sealed with a Teflon-
lined cap, and placed in a sand bath that was maintained at 100-102
°C. The reactions were monitored by TLC, and upon completion, the
reaction mixtures were filtered through Celite. In each case, the residue
was washed with CH2Cl2, and the filtrate was evaporated to dryness.
The products were purified by column chromatography on silica gel
using appropriate solvents (listed under individual compound headings,
vide infra). Fractions that contained the pure products were combined,
evaporated, and finally, dried under high vacuum to remove traces of
solvent.
6-(3-Methoxyphenyl)-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deox-
ynebularine (4c). Chromatography, CH2Cl2. Yellow oil, Rf (CH2-
1
Cl2) ) 0.38. H NMR (CDCl3): 9.01 (s, 1H, purine-H), 8.44 (s, 1H,
purine-H) overlaps with (br d, 1H, Ar-H, J ) 7.0), 8.36 (br s, 1H,
Ar-H), 7.49 (t, 1H, Ar-H, J ) 8.0), 7.09 (dd, 1H, Ar-H, J ) 2.7, 8.2),
6.59 (t, 1H, 1′, J ) 6.5), 4.67 (m, 1H, 3′), 4.07 (app q, 1H, 4′, J ∼
3.5), 3.95 (s, 3H, OCH3), 3.90 (dd, 1H, 5′, J ) 4.1, 11.2), 3.81 (dd,
1H, 5′, J ) 3.2, 11.2), 2.72 (app quint, 1H, 2′, J ∼ 6.3), 2.51 (ddd, 1H,
2′, J ) 3.8, 5.9, 13.0), 0.94, 0.91 (2s, 18H, C(CH3)3), 0.13, 0.10 (2s,
12H, Si-CH3). HRMS calcd for C29H46N4O4Si2Na (M+ + Na),
593.2955. Found, 593.2957.
6-(2-Ethoxyphenyl)-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deoxy-
nebularine (4d). Chromatography, 2% acetone in CH2Cl2. Yellow oil,
1
Rf (2% acetone in CH2Cl2) ) 0.12. H NMR (CDCl3): 9.03 (s, 1H,
purine-H), 8.34 (s, 1H, purine-H), 7.64 (dd, 1H, Ar-H, J ) 1.7, 7.5),
7.45 (dt, 1H, Ar-H, J ) 1.7, 8.4), 7.10 (t, 1H, Ar-H, J ) 7.5), 7.07 (d,
1H, Ar-H, J ) 8.4), 6.58 (t, 1H, 1′, J ) 6.6), 4.66 (m, 1H, 3′), 4.12 (q,
2H, OCH2, J ) 7.0), 4.06 (app q, 1H, 4′, J ∼ 3.6), 3.90 (dd, 1H, 5′,
J ) 4.3, 11.2), 3.80 (dd, 1H, 5′, J ) 3.3, 11.2), 2.76 (app sept, 1H, 2′,
J ) 5.6, 7.0, 13.0), 2.48 (ddd, 1H, 2′, J ) 3.5, 6.0, 13.0), 1.24 (t, 3H,
CH3, J ) 7.0), 0.94, 0.91 (2s, 18H, C(CH3)3), 0.13, 0.09, 0.08 (3s,
12H, Si-CH3). HRMS calcd for C30H49N4O4Si2 (M+ + H), 585.3292.
Found, 585.3286.
2-Phenyl-O6-benzyl-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deoxy-
inosine (5a). Chromatography, 2% EtOAc in CH2Cl2. Colorless foam,
1
Rf (2% EtOAc in CH2Cl2) ) 0.31. H NMR (CDCl3): 8.50 (dd, 2H,
Ar-H, J ) 1.9, 8.2), 8.22 (s, 1H, purine-H), 7.60 (d, 2H, Ar-H, J )
7.2), 7.52-7.29 (m, 6H, Ar-H), 6.57 (t, 1H, 1′, J ) 6.5), 5.81 (AB
quart, 2H, OCH2, J ) 12.1), 4.68 (m, 1H, 3′), 4.05 (app q, 1H, 4′, J ∼
3.8), 3.91 (dd, 1H, 5′, J ) 4.7, 11.0), 3.81 (dd, 1H, 5′, J ) 3.4, 11.0),
2.79 (app quint, 1H, 2′, J ∼ 6.2), 2.48 (ddd, 1H, 2′, J ) 4.0, 6.3, 13.3),
0.95, 0.92 (2s, 18H, C(CH3)3), 0.14, 0.09 (2s, 12H, Si-CH3).
6-(3-Nitrophenyl)-3′,5′-bis-O-(tert-butyldimethylsilyl)-2′-deoxyne-
bularine (4e). Chromatography, 1% acetone in CH2Cl2. Off-white solid,
1
Rf (1% acetone in CH2Cl2) ) 0.37. H NMR (CDCl3): 9.74 (t, 1H,
Ar-H, J ) 1.9), 9.23 (td, 1H, Ar-H, J ) 1.3, 7.9), 9.06 (s, 1H, purine-
H), 8.53 (s, 1H, purine-H), 8.38 (ddd, 1H, Ar-H, J ) 1.0, 2.3, 8.2),
7.75 (t, 1H, Ar-H, J ) 8.0), 6.60 (t, 1H, 1′, J ) 6.4), 4.68 (m, 1H, 3′),
4.08 (app q, 1H, 4′, J ∼ 3.4), 3.91 (dd, 1H, 5′, J ) 4.1, 11.2), 3.82
(dd, 1H, 5′, J ) 3.1, 11.2), 2.72 (app quint, 1H, 2′, J ∼ 5.9), 2.53
(ddd, 1H, 2′, J ) 3.9, 6.1, 13.1), 0.94, 0.93 (2s, 18H, C(CH3)3), 0.13,
2-(4-Methoxyphenyl)-O6-benzyl-3′,5′-bis-O-(tert-butyldimethylsi-
lyl)-2′-deoxyinosine (5b). Chromatography, 5% EtOAc in CH2Cl2.
Colorless foam, Rf (5% EtOAc in CH2Cl2) ) 0.49. 1H NMR (CDCl3):
8.45 (d, 2H, Ar-H, J ) 9.0), 8.19 (s, 1H, purine-H), 7.59 (d, 2H, Ar-